Large-scale testing (Phase 3)Study completedNCT03924986
What this trial is testing
Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC)
Who this might be right for
Recurrent or Metastatic Nasopharyngeal Cancer
BeiGene 263